ranbaxy (drug)

literal strings: ranbaxy, RANBAXY, Ranbaxy

categories

NELL has only weak evidence for items listed in grey

• drug
• SEAL @125 (50.0%) on 20-jun-2010 [ 1 ] using ranbaxy

relations

NELL has only weak evidence for items listed in grey

• acquiredby
• daiichi_sankyo
• CPL @1095 (93.8%) on 17-jan-2018 [ "arg1 announced that it would acquire arg2" "arg1 has acquired arg2" "arg1 acquired arg2" "arg1 announced plans to acquire arg2" ] using (daiichi_sankyo, ranbaxy)
• agentcollaborateswithagent
• daiichi
• OE @1009 (93.9%) on 30-jul-2016 [ http://www.fiercepharma.com/story/daiichi-sankyo-cashing-out-after-merging-ranbaxy-sun/2015-04-20 http://www.slideshare.net/NiharRoutray/acquisition-of-ranbaxy-by-daichii http://www.slideshare.net/NiharRoutray/acquisition-of-ranbaxy-by-daichii http://profit.ndtv.com/news/interviews/article-daiichi-the-only-loser-in-sun-pharma-ranbaxy-deal-adige-384880 http://www.financialexpress.com/article/industry/companies/for-daiichi-side-effects-of-ranbaxy-refuse-to-wane/72637/ http://qz.com/196113/daiichi-sankyos-ranbaxy-sell-off-highlights-the-pitfalls-of-making-drugs-in-india/ http://www.fiercepharma.com/story/daiichi-sankyo-cashing-out-after-merging-ranbaxy-sun/2015-04-20 http://www.jonesday.com/daiichi-sankyo-acquires-generic-drug-maker-ranbaxy-laboratories-for-46-billion/ http://www.slideshare.net/NiharRoutray/acquisition-of-ranbaxy-by-daichii http://www.wsj.com/articles/SB10001424052702303456104579487381613887674 http://www.vccircle.com/news/pharmaceuticals/2015/04/21/daiichi-sankyo-sells-entire-89-stake-sun-pharma-over-3b-exit-india http://www.slideshare.net/NiharRoutray/acquisition-of-ranbaxy-by-daichii http://profit.ndtv.com/news/interviews/article-daiichi-the-only-loser-in-sun-pharma-ranbaxy-deal-adige-384880 http://www.slideshare.net/NiharRoutray/acquisition-of-ranbaxy-by-daichii https://en.wikipedia.org/wiki/Ranbaxy_Laboratories http://www.slideshare.net/NiharRoutray/acquisition-of-ranbaxy-by-daichii http://www.financialex  ] using (ranbaxy, daiichi)
• OE @1009 (93.9%) on 30-jul-2016 [ http://www.fiercepharma.com/story/daiichi-sankyo-cashing-out-after-merging-ranbaxy-sun/2015-04-20 http://www.slideshare.net/NiharRoutray/acquisition-of-ranbaxy-by-daichii http://www.slideshare.net/NiharRoutray/acquisition-of-ranbaxy-by-daichii http://profit.ndtv.com/news/interviews/article-daiichi-the-only-loser-in-sun-pharma-ranbaxy-deal-adige-384880 http://www.financialexpress.com/article/industry/companies/for-daiichi-side-effects-of-ranbaxy-refuse-to-wane/72637/ http://qz.com/196113/daiichi-sankyos-ranbaxy-sell-off-highlights-the-pitfalls-of-making-drugs-in-india/ http://www.fiercepharma.com/story/daiichi-sankyo-cashing-out-after-merging-ranbaxy-sun/2015-04-20 http://www.jonesday.com/daiichi-sankyo-acquires-generic-drug-maker-ranbaxy-laboratories-for-46-billion/ http://www.slideshare.net/NiharRoutray/acquisition-of-ranbaxy-by-daichii http://www.wsj.com/articles/SB10001424052702303456104579487381613887674 http://www.vccircle.com/news/pharmaceuticals/2015/04/21/daiichi-sankyo-sells-entire-89-stake-sun-pharma-over-3b-exit-india http://www.slideshare.net/NiharRoutray/acquisition-of-ranbaxy-by-daichii http://profit.ndtv.com/news/interviews/article-daiichi-the-only-loser-in-sun-pharma-ranbaxy-deal-adige-384880 http://www.slideshare.net/NiharRoutray/acquisition-of-ranbaxy-by-daichii https://en.wikipedia.org/wiki/Ranbaxy_Laboratories http://www.slideshare.net/NiharRoutray/acquisition-of-ranbaxy-by-daichii http://www.financialex  ] using (daiichi, ranbaxy)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" "Y~X0~concept:agentcontrols,concept:agenthierarchicallybelowagent,concept:agentcontrols" ] using (daiichi, ranbaxy)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" "Y~X0~concept:agentcontrols,concept:agenthierarchicallybelowagent,concept:agentcontrols" ] using (ranbaxy, daiichi)
• daiichi_sankyo
• OE @1009 (93.0%) on 30-jul-2016 [ http://www.slideshare.net/Adityakapoors/sec-abc-group-3-case-daiichi-sankyo http://www.slideshare.net/Adityakapoors/sec-abc-group-3-case-daiichi-sankyo http://www.slideshare.net/Adityakapoors/sec-abc-group-3-case-daiichi-sankyo http://www.jonesday.com/daiichi-sankyo-acquires-generic-drug-maker-ranbaxy-laboratories-for-46-billion/ http://www.wsj.com/articles/SB10001424052702303456104579487381613887674 http://www.vccircle.com/news/pharmaceuticals/2015/04/21/daiichi-sankyo-sells-entire-89-stake-sun-pharma-over-3b-exit-india http://www.bloomberg.com/news/articles/2014-05-15/daiichi-sankyo-chairman-shoda-steps-down-amid-ranbaxy-sale  ] using (ranbaxy, daiichi_sankyo)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" "Y~X0~concept:agentcontrols,concept:agenthierarchicallybelowagent,concept:agentcontrols" ] using (ranbaxy, daiichi_sankyo)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" "Y~X0~concept:agentcontrols,concept:agenthierarchicallybelowagent,concept:agentcontrols" ] using (daiichi_sankyo, ranbaxy)
• OE @1009 (93.0%) on 30-jul-2016 [ http://www.slideshare.net/Adityakapoors/sec-abc-group-3-case-daiichi-sankyo http://www.slideshare.net/Adityakapoors/sec-abc-group-3-case-daiichi-sankyo http://www.slideshare.net/Adityakapoors/sec-abc-group-3-case-daiichi-sankyo http://www.jonesday.com/daiichi-sankyo-acquires-generic-drug-maker-ranbaxy-laboratories-for-46-billion/ http://www.wsj.com/articles/SB10001424052702303456104579487381613887674 http://www.vccircle.com/news/pharmaceuticals/2015/04/21/daiichi-sankyo-sells-entire-89-stake-sun-pharma-over-3b-exit-india http://www.bloomberg.com/news/articles/2014-05-15/daiichi-sankyo-chairman-shoda-steps-down-amid-ranbaxy-sale  ] using (daiichi_sankyo, ranbaxy)
• agentworkedondrug
• enalapril
• SEAL @523 (50.0%) on 02-mar-2012 [ 1 ] using (enalapril, ranbaxy)
• physiologicalconditionpossiblytreatedbydrug
• imitrex
• CPL @1100 (50.0%) on 31-jan-2018 [ "arg1 drug for arg2" ] using (imitrex, ranbaxy)